A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
Trial details
- Registry ID
- NCT07771465
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated CardiomyopathyNCT07771465 | KARD | Phase 3 | Recruiting | 2032-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |